Kathrin Tollner
Hannover, NI, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 30 publications
Deletion of the Na-K-2Cl cotransporter NKCC1 results in a more severe epileptic phenotype in the intrahippocampal kainate mouse model of temporal lobe epilepsy.
Journal: Neurobiology of disease
Published: January 06, 2021
Disruption of the sodium-dependent citrate transporter SLC13A5 in mice causes alterations in brain citrate levels and neuronal network excitability in the hippocampus.
Journal: Neurobiology of disease
Published: May 04, 2020
Proof-of-concept that network pharmacology is effective to modify development of acquired temporal lobe epilepsy.
Journal: Neurobiology of disease
Published: August 06, 2019
Network pharmacology for antiepileptogenesis: Tolerability and neuroprotective effects of novel multitargeted combination treatments in nonepileptic vs. post-status epilepticus mice.
Journal: Epilepsy research
Published: November 20, 2018
Bumepamine, a brain-permeant benzylamine derivative of bumetanide, does not inhibit NKCC1 but is more potent to enhance phenobarbital's anti-seizure efficacy.
Journal: Neuropharmacology
Published: July 18, 2018
Cerebral influx of Na+ and Cl- as the osmotherapy-mediated rebound response in rats.
Journal: Fluids and barriers of the CNS
Published: June 08, 2018
A combination of NMDA and AMPA receptor antagonists retards granule cell dispersion and epileptogenesis in a model of acquired epilepsy.
Journal: Scientific reports
Published: May 22, 2017
The intrahippocampal kainate mouse model of mesial temporal lobe epilepsy: Lack of electrographic seizure-like events in sham controls.
Journal: Epilepsia open
Published: January 24, 2017
Multiple blood-brain barrier transport mechanisms limit bumetanide accumulation, and therapeutic potential, in the mammalian brain.
Journal: Neuropharmacology
Published: November 16, 2016
Various modifications of the intrahippocampal kainate model of mesial temporal lobe epilepsy in rats fail to resolve the marked rat-to-mouse differences in type and frequency of spontaneous seizures in this model.
Journal: Epilepsy & behavior : E&B
Published: October 12, 2016
Gene therapy decreases seizures in a model of Incontinentia pigmenti.
Journal: Annals of neurology
Published: September 23, 2016
Last Updated: 09/26/2026